Biotech IPOs: Intra-Cellular Therapies, 10x Genomics and Spero Therapeutics

Biotech IPOs: Intra-Cellular Therapies, 10x Genomics and Spero Therapeutics

Source: 
BioSpace
snippet: 

It was a busy week for biopharma, biotech and medical device initial public offerings (IPOs). Here’s a look.